UTI Asset Management Company LtdQ4 FY22

UTI Asset Management Company Ltd Q4 FY22 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹878P/E: 21.7Market Cap: ₹11.6K CrSector: Capital Markets

Management growth scorecard

Revenue

Category 3

Margin

Category 3

Fundraise

N/A

Order

N/A

Capex

N/A

0 of 2 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 3
- UTI Mutual Fund expects continued growth in AUM, having already registered a 22.4% YoY increase to Rs. 2,23,842 crore as of March 2022. - Net sales for FY 2021-22 were Rs. 19,428 crore, a 55% increase over the previous year, with equity net inflows notably improving. - Focus is on growing high yield assets, passive funds (smart beta), and filling product gaps, such as the planned Multi Asset Fund launch within the financial year. - SIP (Systematic Investment Plans) accounts and AUM are growing strongly, with SIP folios rising 45%, SIP AUM up 31.6%, and SIP inflows for Q4 up 10.1% QoQ. - International business inflows and broad investor base expansion continue, despite MTM fluctuations. - Business growth will also drive variable pay and employee cost dynamics, indicating optimism on sustained growth. - Digital initiatives aim to improve customer experience and distribution reach to support growth. Overall, UTI AMC is positioned for sustained growth through product innovation, market share expansion, and operational improvements.

See what UTI Asset Management Company Ltd management said on margin guidance — free account, 30 seconds.

Fundraise plans

  • There is no specific mention of any current or upcoming fundraising through debt or equity in the provided transcript.
  • The focus appears to be on managing employee costs, operational efficiencies, and growth through product launches, especially in passive funds and a Multi Asset Fund under consideration.
  • The company is also working on business expansion, including international business and retirement solutions, without indicating any new capital raising plans.
  • Discussions highlight cost management and performance incentives rather than capital infusion.
  • No explicit guidance or announcement regarding debt or equity fundraising was provided in the Q&A or management commentary.

See what UTI Asset Management Company Ltd management said on order book — free account, 30 seconds.

Capex plans

Based on the provided transcript, there is no explicit mention of any current or future capex, capital investment, or strategic investment plans. However, some related points are: - The company is investing in **digital initiatives**, including redesigning and upgrading digital assets like UTI MF App, UTI Buddy App, and Website with a mobile-first approach and e-commerce experience (Page 8). - They are enhancing **digital distribution outreach** through partnerships with distributors and third-party portals via API gateways for onboarding and transactions (Page 8). - They appointed **BCG consulting services** (Rs. 2 crore paid) to develop business plans and guidelines for diversifying UTI Retirement Solutions into the private sector (Page 22). - UTI Capital has SEBI approvals to launch new schemes and is expected to break even in two years, indicating future strategic moves (Page 7). No direct details about capital expenditure or large-scale strategic investments were disclosed.

Track UTI Asset Management Company Ltd — get its next earnings analysis in your feed

How does UTI Asset Management Company Ltd rank vs peers in Capital Markets?

Pro feature
ThisUTI Asset Management Company Ltd
Rev 3Mar 3

How does UTI Asset Management Company Ltd rank in Capital Markets?

Compare UTI Asset Management Company Ltd against every Capital Markets company (Q4 FY22) on revenue, margins and earnings-call signals.

View Capital Markets leaderboard →

Others in Capital Markets this season

  • CARE Ratings Ltd (Q1 FY25)

    78.92 Crs, up 19% YoY (Page 13) . Key concall takeaways from CARE Ratings Ltd's Q1 FY25 earnings call — and how it ranks against sector peers.

  • ICRA Ltd (Q3 FY25)

    Q3 FY2025 Revenue: ₹120.9 crore, up 5.5% YoY from ₹114.6 crore in Q3 FY2024 (Page 6). Key concall takeaways from ICRA Ltd's Q3 FY25 earnings call — and how it…

  • CARE Ratings Ltd (Q3 FY26)

    90.24 Crs, up 15% YoY (Page 12, 2) . Key concall takeaways from CARE Ratings Ltd's Q3 FY26 earnings call — and how it ranks against sector peers.

  • CARE Ratings Ltd (Q1 FY27)

    111.68 Cr, up 18.9% YoY (Page 2, 13) . Key concall takeaways from CARE Ratings Ltd's Q1 FY27 earnings call — and how it ranks against sector peers.

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →